Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00267553
Status:
TERMINATED
Last Update Posted:
2007-09-10
First Post:
2005-12-20
Brief Title:
Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer
Sponsor:
Intarcia Therapeutics
Organization:
Intarcia Therapeutics
Organization Data
Organization:
Intarcia Therapeutics
Class:
INDUSTRY
Study ID:
Biomed 777-CLP-32
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Intarcia Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None